Long-term survival probability in men with clinically localized prostate cancer treated either conservatively or with definitive treatment (radiotherapy or radical prostatectomy)

Urology

Volumn 68, Issue 6, 2006, Pages 1268-1274

  Tewari, Ashutosh ^a   Raman, Jay D ^a   Chang, Peter ^a   Rao, Sandhya ^a   Divine, George ^b   Menon, Mani ^b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b Josephine Ford Cancer Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BIOPSY; CANCER GRADING; CANCER RADIOTHERAPY; CANCER SURVIVAL; COMORBIDITY; COMPARATIVE STUDY; CONSERVATIVE TREATMENT; CONTROLLED STUDY; HAZARD ASSESSMENT; HUMAN; INCOME; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROBABILITY; PROSTATE CANCER; PROSTATECTOMY; RACE; REGRESSION ANALYSIS; RISK ASSESSMENT; SURVIVAL RATE; SURVIVAL TIME; TIME SERIES ANALYSIS;

AGED; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROSTATECTOMY; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; TIME FACTORS;

EID: 33845315227     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2006.08.1059     Document Type: Article

References (26)

1. Catalona W.J. Management of cancer of the prostate. N Engl J Med 331 (1994) 996-1004
2. Shipley W.U., Thames H.D., Sandler H.M., et al. Radiation therapy for clinically localized prostate cancer: a multi-institutional pooled analysis. JAMA 281 (1999) 1598-1604
3. Menon M., Parulkar B.G., and Baker S. Should we treat localized prostate cancer?. An opinion. Urology 46 (1995) 607-616
4. Holmberg L., Bill-Axelson A., Helgesen F., et al. A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer. N Engl J Med 347 (2002) 781-789
5. Bill-Axelson A., Holmberg L., Ruutu M., et al. Scandinavian Prostate Cancer Group Study No 4: radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med 352 (2005) 1977-1984
6. Walsh P.C., and Brooks J.D. The Swedish prostate cancer paradox. JAMA 277 (1997) 497-498
7. Lu-Yao G.L., and Yao S.L. Population-based study of long-term survival in patients with clinically localised prostate cancer. Lancet 349 (1997) 906-910
8. Benson K., and Hartz A.J. A comparison of observational studies and randomized, controlled trials. N Engl J Med 342 (2000) 1878-1886
9. Concato J., Shah N., and Horwitz R.I. Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med 342 (2000) 1887-1892
10. Albertsen P.C., Hanley J.A., Gleason D.F., et al. Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer. JAMA 280 (1998) 975-980
11. Fowler Jr. J.E., Terrell F.L., and Renfroe D.L. Co-morbidities and survival of men with localized prostate cancer treated with surgery or radiation therapy. J Urol 156 (1996) 1714-1718
12. Calle E.E., and Terrell D.D. Utility of the National Death Index for ascertainment of mortality among cancer prevention study II participants. Am J Epidemiol 137 (1993) 235-241
13. Wright J.C., and Weinstein M.C. Gains in life expectancy from medical interventions-standardizing data on outcomes. N Engl J Med 339 (1998) 380-386
14. Tewari A., Issa M., El-Galley R., et al. Genetic adaptive neural network to predict biochemical failure after radical prostatectomy: a multi-institutional study. Mol Urol 5 (2001) 163-169
15. Pound C.R., Partin A.W., Epstein J.I., et al. Prostate-specific antigen after anatomic radical retropubic prostatectomy: patterns of recurrence and cancer control. Urol Clin North Am 24 (1997) 395-406
16. Chodak G.W., Thisted R.A., Gerber G.S., et al. Results of conservative management of clinically localized prostate cancer. N Engl J Med 330 (1994) 242-248
17. Djavan B., Kadesky K., Klopukh B., et al. Gleason scores from prostate biopsies obtained with 18-gauge biopsy needles poorly predict Gleason scores of radical prostatectomy specimens. Eur Urol 33 (1998) 261-270
18. Fernandes E.T., Sundaram C.P., Long R., et al. Biopsy Gleason score: how does it correlate with the final pathological diagnosis in prostate cancer?. Br J Urol 79 (1997) 615-617
19. McLean M., Srigley J., Banerjee D., et al. Interobserver variation in prostate cancer Gleason scoring: are there implications for the design of clinical trials and treatment strategies?. Clin Oncol 9 (1997) 222-225
20. Pound C.R., Partin A.W., Eisenberger M.A., et al. Natural history of progression after PSA elevation following radical prostatectomy. JAMA 281 (1999) 1591-1597
21. Dale W., Vijayakumar S., Lawlor E.F., et al. Prostate cancer, race, and socioeconomic status: inadequate adjustment for social factors in assessing racial differences. Prostate 29 (1996) 271-281
22. Krieger N., Chen J.T., and Ebel G. Can we monitor socioeconomic inequalities in health? A survey of U.S. health departments' data collection and reporting practices. Public Health Rep 112 (1997) 481-491
23. Krieger N., Williams D.R., and Moss N.E. Measuring social class in US public health research: concepts, methodologies, and guidelines. Annu Rev Public Health 18 (1997) 341-378
24. Albertsen P.C., Hanley J.A., and Fine J. 20-year outcomes following conservative management of clinically localized prostate cancer. JAMA 293 (2005) 2095-2101
25. Johannson J.E., Andren O., Andersson S.O., et al. Natural history of early, localized prostate cancer. JAMA 291 (2004) 2713-2719
26. Donovan J., Hamdy F., Neal D., et al. Prostate Testing For Cancer and Treatment (ProtecT) feasibility study. Health Technol Assess 7 (2003) 1-88